Pol F. Boudes

Insider Reports History

Location
Carmiel
Signature
/s/ Joseph R. Magnas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pol F. Boudes:

Stock Role Class Num Shares Value Price $ Report Date Ownership
GALECTIN THERAPEUTICS INC Chief Medical Officer Restricted Stock Unit 40K $71.4K $1.79 24 Jan 2024 Direct
Protalix BioTherapeutics, Inc. Director Common Stock 7.5K $11.6K $1.55 03 Sep 2025 By Trust
GALECTIN THERAPEUTICS INC Chief Medical Officer Stock Option (right to buy) 65K 24 Jan 2024 Direct
Protalix BioTherapeutics, Inc. Director Stock Options (Right to Buy) 15K 03 Sep 2025 Direct
Protalix BioTherapeutics, Inc. Director Commn Stock 40 03 Sep 2025 Direct

Insider Reports Filed by Pol F. Boudes

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PLX Protalix BioTherapeutics, Inc. 03 Sep 2025 2 $0 4 Director 04 Sep 2025, 17:00
GALT GALECTIN THERAPEUTICS INC 24 Jan 2024 2 $0 4 Chief Medical Officer 07 Feb 2024, 16:43
PLX Protalix BioTherapeutics, Inc. 29 Sep 2023 1 $0 4 Director 03 Oct 2023, 17:00
GALT GALECTIN THERAPEUTICS INC 26 Jan 2023 1 $0 4 Chief Medical Officer 30 Jan 2023, 15:37
PLX Protalix BioTherapeutics, Inc. 07 Sep 2022 1 $0 4 Director 09 Sep 2022, 17:00
GALT GALECTIN THERAPEUTICS INC 24 Jan 2022 1 $0 4 Chief Medical Officer 25 Jan 2022, 15:17